Loading
A phase 2 trial in colorectal cancer, run by The Second Hospital of Nanjing Medical University, now recruiting.
Fluorouracil Treatment Via Colon for Colorectal Cancer is a phase 2, interventional study registered as NCT06385418 by The Second Hospital of Nanjing Medical University, with a registry enrolment figure of 40 participants, started 2024-05-16 and due to reach its primary completion in 2028-05-01. Interventions recorded: Colonic local administration of fluorouracil with enhanced adhesion. Conditions listed: Colorectal Cancer. Primary outcome: Objective response rate (according to RECIST1.1, investigator assessment). Colorectal eligibility wording from the registry: "Histologically confirmed diagnosis of colorectal cancer with measurable primary lesion according to RECIST 1". Sites: China. No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.